Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. The firm is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Follow-Up Questions
Haemonetics Corp (HAE) の株価収益率はいくらですか？
Haemonetics Corp の株価収益率は 14.1217 です。
Haemonetics Corp のCEOは誰ですか？
Mr. Christopher Simon は Haemonetics Corp の President で、2016 から在籍しています。
HAE の株価パフォーマンスは？
HAE の現在の価格は $51.27 で、最終取引日から 0.03% increased 変動しました。
Haemonetics Corp の主な事業テーマや業界は？
Haemonetics Corp は Health Care 業界、セクターは Health Care に属しています。
